Maa: Singapore
Kieli: englanti
Lähde: HSA (Health Sciences Authority)
Pralsetinib
ROCHE SINGAPORE PTE. LTD.
L01EX23
CAPSULE
Pralsetinib 100.0mg
ORAL
Prescription Only
Catalent CTS, LLC
ACTIVE
2023-04-06
1 Please visit www.roche.com.sg/pharma/gavreto for a printable version of this leaflet. CAP-GAV-2023 09 GAVRETO ™ Pralsetinib 1. DESCRIPTION 1.1 THERAPEUTIC / PHARMACOLOGIC CLASS OF DRUG Pharmacotherapeutic group: Antineoplastic agent, protein kinase inhibitors ATC code: L01EX23 1.2 TYPE OF DOSAGE FORM Hard Capsule Gavreto 100mg are size 0 light blue opaque HPMC capsules, printed in white ink with “BLU-667” on the capsule shell body and “100mg” on the capsule shell cap, containing white to off white powder. 1.3 ROUTE OF ADMINISTRATION Oral 1.4 STERILE / RADIOACTIVE STATEMENT Not applicable 1.5 QUALITATIVE AND QUANTITATIVE COMPOSITION _Active ingredient(s):_ pralsetinib _Excipients: _ _Capsule content: hydroxypropyl methylcellulose, microcrystalline cellulose, sodium _ _bicarbonate, citric acid, anhydrous, magnesium stearate, pregelatinized starch. _ _Capsule shell: hypromellose, titanium dioxide, FD&C Blue #1 (Brilliant Blue FCF) _ _Printing ink: _shellac, dehydrated alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, strong ammonia solution, purified water, potassium hydroxide, and titanium dioxide. 2 2. CLINICAL PARTICULARS 2.1 THERAPEUTIC INDICATION(S) _NON-SMALL CELL LUNG CANCER (NSCLC) _ Gavreto is indicated for the treatment of adult patients with rearranged during transfection (_RET_) fusion-positive, locally advanced or metastatic NSCLC. _RET-MUTANT MEDULLARY THYROID CANCER (MTC) _ Gavreto is indicated for the treatment of adult patients with locally advanced or metastatic _RET_-mutant MTC who require systemic therapy. 2.2 DOSAGE AND ADMINISTRATION _GENERAL _ A validated assay is required for the selection of patients with a _RET_-gene fusion (NSCLC) or a _RET_-gene mutation (MTC). _DOSAGE _ Gavreto hard capsules should be taken on an empty stomach. Do not to eat for at least 2 hours before and at least 1 hour after taking Gavreto. Gavreto hard capsules should be swallowed whole with a glass of water and must not be opened or chewed. _ADULTS _ The recommended dose of Gavreto for adults Lue koko asiakirja